Total Cardiology and Vascular Solutions

This tender for Total Cardiology and Vascular Solutions is well-structured with a clear lot division and substantial estimated value. However, it relies heavily on external documentation for critical details, impacting completeness and clarity.

The tender appears to comply with general procurement regulations, including the use of a proper CPV code and an open procedure. Deadlines are provided, though their adequacy for a tender of this scale is not fully assessable without knowing the complexity of the documentation. No disputes are flagged. The use of an e-procurement portal suggests adherence to modern legal frameworks.

The overall description of the framework and its purpose is clear. The lot structure is well-defined, providing a good overview of the scope. However, specific requirements for each lot, technical capabilities, and financial criteria are deferred to external documents (ITT_2152), which reduces the immediate clarity of the tender.

Basic information such as title, organization, estimated value, and contract duration are present. The CPV code and NUTS code are provided. However, crucial details regarding mandatory exclusion grounds, financial requirements, and technical capabilities are explicitly stated to be within ITT_2152, making the tender notice itself incomplete. The lack of content summaries for attached documents is also a drawback.

The tender is open to all suppliers, and the use of an e-procurement portal promotes transparency. The estimated value is disclosed, and the lot structure allows for specialized participation. There are no immediately apparent requirements tailored to specific companies. The criteria for evaluation are not specified in the notice, which is a concern for fairness.

The tender mandates e-submission via a specified portal, which is a positive aspect. The contract start date and duration are provided. However, the reliance on external documents (ITT_2152) for essential information adds a layer of complexity to the practical execution of the submission process. Financing information is not explicitly detailed in the notice.

Key fields such as title, reference, organization, value, and dates are populated. The tender is active and has no flagged disputes or suspensions. The contract start date (2027-02-27) is logically after the submission deadline (2026-04-30). The estimated value is consistent across different mentions.

The tender notice does not explicitly mention any green procurement, social aspects, or innovation focus. It is also not indicated as EU funded. This suggests a lack of emphasis on sustainability criteria within the tender itself.